R D MacArthur
Overview
Explore the profile of R D MacArthur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Achhra A, Phillips A, Emery S, MacArthur R, Furrer H, de Wit S, et al.
HIV Med
. 2015 May;
16(7):449-54.
PMID: 25959989
Objectives: Pre-antiretroviral therapy (ART) inflammation and coagulation activation predict clinical outcomes in HIV-positive individuals. We assessed whether pre-ART inflammatory marker levels predicted the CD4 count response to ART. Methods: Analyses...
2.
Lin F, Ying H, MacArthur R, Cohn J, Barth-Jones D, Crane L
Inf Sci (N Y)
. 2009 Jun;
177(18):3749-3763.
PMID: 19562097
The primary goal of the study presented in this paper is to develop a novel and comprehensive approach to decision making using fuzzy discrete event systems (FDES) and to apply...
3.
MacArthur R, Chen L, Peng G, Novak R, van den Berg-Wolf M, Kozal M, et al.
HIV Clin Trials
. 2005 Feb;
5(6):361-70.
PMID: 15682349
Purpose: The combination of abacavir + lamivudine (ABC+3TC) versus didanosine + stavudine (ddI+d4T), each combined with other classes of antiretrovirals (ARVs) in ARV-naive patients, was compared for the combined endpoint...
4.
MacArthur R, Chen L, Mayers D, Besch C, Novak R, van den Berg-Wolf M, et al.
Control Clin Trials
. 2001 Apr;
22(2):176-90.
PMID: 11306155
The CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial is a large, long-term, randomized, prospective comparison of three different antiretroviral...
5.
MacArthur R
AIDS Read
. 2001 Feb;
10(11):652-7.
PMID: 11186189
Genotypic antiretroviral resistance testing (GART) has been shown to be of value in selecting antiretroviral therapy. Unfortunately, GART reports often are difficult to interpret and, at times, can be misleading....
6.
Birk T, McGrady A, MacArthur R, Khuder S
J Altern Complement Med
. 2000 Nov;
6(5):405-14.
PMID: 11059502
Objectives: Determine effects of massage therapy alone and in combination with exercise or stress management-biofeedback treatment on enumerative immune measures, and quality of life in moderately immunocompromised human immunodeficiency virus...
7.
MacArthur R
AIDS Read
. 2000 Jul;
10(6):359-64.
PMID: 10881367
Sequencing of antiretroviral agents is of interest because the majority of HIV-infected individuals in clinical practice experience virologic rebound after 1 to 2 years of therapy. Sequencing strategies are based...
8.
Kak V, MacArthur R, Crane L
Semin Thorac Cardiovasc Surg
. 2000 May;
12(2):140-4.
PMID: 10807436
Highly active antiretroviral therapy (HAART), which typically consists of 3-drug combinations of antiretroviral agents, has decreased dramatically the incidence of AIDS and death among HIV-infected persons in the United States....
9.
Hidalgo J, MacArthur R, Crane L
Semin Thorac Cardiovasc Surg
. 2000 May;
12(2):130-9.
PMID: 10807435
Thanks to a worldwide collaborative effort among health care providers, academia, governments, and industry, our knowledge base about infection caused by the human immunodeficiency virus (HIV) has expanded exponentially. During...
10.
MacArthur R, Lederman M, Benson C, Chernoff M, MacGregor R, Spritzler J, et al.
J Infect Dis
. 2000 Apr;
181(4):1486-90.
PMID: 10762582
Human immunodeficiency virus (HIV) type 1-infected persons with newly diagnosed Mycobacterium avium complex (MAC) bacteremia were enrolled in an 8-week study to determine whether treatment of MAC infection is associated...